We manufacture a wide range of cell types for CELL&GENE therapies

AUTOLOGOUS AND ALLOGENIC CELL TYPES

CELLforCURE by SEQENS is designed to support the needs of cell and gene therapy programs by offering a wide range of cell type manufacturing capability and expertise.

CAR-T cells
Regulatory T Cells
TILs (Tumor-Infiltrating Lymphocytes)
NK Cells (Natural Killer Cells)
iPSCs (induced Pluripotent Stem Cells )
MSCs (Mesenchymal Stem Cells)
HSCs (Hematopoietic Stem Cells)
Muscular cells
Epithelial cells

At CELLforCURE by SEQENS

Our facility provides end-to-end versatile services, enabling small to large-scale production, all within a single location.

From process and analytical development to seamless tech transfer and GMP manufacturing, we ensure the highest standards of quality control. Our integrated approach simplifies product release, offering a comprehensive solution for your cell and gene therapy needs. With cutting-edge technology and expertise, CELLforCURE by SEQENS is fully committed to delivering reliable solutions that meet regulatory requirements.

Process and Analytical Development,
Scale up and Industrialisation

CELLforCURE by SEQENS development team works hand in hand with R&D customer teams to bring processes and analytics to GMP sustainable standard.

CELLforCURE by SEQENS Chemistry Manufacturing and Control (CMC) approach includes :

Process scale up
Equipment testing and qualification
Key quality attribute definition and qualification
IND and regulatory submission support

CELLforCURE by SEQENS development team welcomes R&D customer team on site to strengthen collaboration.

CELLforCURE by SEQENS development lab is designed to facilitate transition to GMP manufacturing lines.

Technology Transfer Strategy

CELLforCURE by SEQENS’ “One-Stop-Shop” approach delivers significant efficiency gains and operational synergies. It aims at ensuring strong reliability and time savings.

Same equipment in both Development and GMP areas
One single team handles projects from Tech Transfer to GMP production

Enhanced training and expertise of the project team ensure consistency and reliability, with the goal of accelerating the transfer time.

Fully internalized Quality Control
for quick batch release

CELLforCURE by SEQENS is equipped with state-of-the-art equipment, enabling a wide range of in-house quality control for raw materials, intermediates, and finished products

Raw materials testing
In-process QC
Environmental monitoring
Final product QC & batch release
Sterility, identity, potency, stability